As our conference season kicks off, we’re looking forward to connecting with quality professionals across the industry and hearing first-hand about the challenges, priorities, and opportunities shaping the GxP landscape. 

Whether through discussions at our exhibition stand or topics raised during workshops, presentations, and panel sessions, many of the same issues continue to surface across the industry.

Below, we outline 25 key learnings. 

  1. Market Needs Are Shifting Toward Integrated QA – Attendees increasingly want bundled solutions spanning Quality Management, Regulatory Intelligence, and Computerised System Validation. 
  2. Regulators Are Active Conversational Partners – Sessions featuring MHRA/EMA/ICH speakers confirmed that regulators expect proactive quality cultures, not just reactive compliance. 
  3. Clinical Ops & QA Are Converging – Outsourcing in clinical trials discussions highlighted interconnected risk management between QA and clinical operations. 
  4. Risk-Based Quality Is No Longer Optional – Delegates are embedding risk frameworks across GxP (preclinical → clinical → manufacturing) and demand practical support. 
  5. Digital Tools Drive Efficiency Expectations – Vendors and attendees alike are prioritising solutions for e-document control, CAPA tracking, metrics dashboards, and audit readiness. 
  6. Data Integrity Remains a Top Concern Across GxP Domains – From lab informatics to clinical data, sponsors and service providers want demonstrable controls and assurance. 
  7. Vendor Qualification & Oversight Has Become More Scrutinised – Particularly in clinical outsourcing, questions centred on how QA services ensure vendor performance and compliance oversight. 
  8. Training & Competency Are Strategic Investments – Participants repeatedly asked for modular, role-based training rather than generic compliance training. 
  9. Smaller Teams Lack Robust QA experience – Exhibitor booth interactions showed many early sponsors require external governance frameworks. 
  10. Standard Operating Procedure (SOP) Harmonisation Is a Recurrent Pain Point – Sponsors are asking how to standardise across global sites and units without undue bureaucracy. 
  11. Artificial Intelligence in QA Raises Both Opportunity and Concern – Attendees want guidance on AI validation, risk controls, and regulatory acceptance. 
  12. Remote Auditing Is A Mainstay, Not a Stopgap – Even post-pandemic, remote and hybrid audit models are regularly debated and used as part of a risk-based approach. 
  13. Quality Culture Is Tangible and Measurable – Conference discussions elevated quality culture from an abstract concept to a set of assessable behaviours and metrics. 
  14. Clinical Quality Agreements and Oversight Plans Are Underutilised – Outsourcing sessions emphasised gaps in agreement scope and monitoring practices. 
  15. Inspection Preparedness Drives Investment Decisions – Exhibitors heard repeatedly that organisations are buying into solutions to “get and stay inspection-ready.” 
  16. Regulatory Intelligence Services Are Valued for Early Warning of Change – Stakeholders want curated, practical updates rather than raw guidance dumps. 
  17. Benchmarking and Peer Networks Are Highly Valued – Many attendees asked how their QA maturity compared to industry peers. 
  18. Quality Metrics Must Tie Back to Business Outcomes – KPI/metrics discussions stressed linking quality indicators to patient safety and business continuity. 
  19. Vendor Management Tools Are Fundamental for Sponsors and CROs – Especially in clinical outsourcing, the need for systematic vendor performance tracking was clear. 
  20. Documentation Burden Remains a Barrier – Attendees seek approaches that reduce overhead without sacrificing compliance. 
  21. Interoperability Across Systems Was Highlighted in Tech Panels – QA leaders want platforms that connect eQMS, EDM, LMS, and audit workflows. 
  22. Multi-Jurisdictional Regulatory Variance Is a Persistent Challenge – Delegates from APAC, EU, UK, and US all highlighted differences in expectations and interpretations. 
  23. Case Studies Transform Abstract Concepts into Operational Guidance – Roundtables or training that showcase real remediation stories have the highest engagement. 
  24. Outsourced QA Support Is Increasingly Strategic, Not Tactical – Organisations with limited internal QA are looking for long-term partners rather than ad-hoc contractors. 
  25. Thought Leadership Matters in choosing Service Providers – Access to experts and facilitation of problem solving significantly increase credibility and lead quality. 

Taken together, these insights show that quality assurance is becoming increasingly strategic, cross-functional, and technology-driven. 

While the challenges may vary across different sectors, the priorities remain the same: organisations want practical support, stronger oversight, better systems, and greater confidence in their ability to remain inspection ready. 

As conference season continues, we look forward to hearing more perspectives, sharing experiences, and continuing the conversation around the future of quality assurance.